Long-Acting Injectables Public Comments
BACK TO LAIS MAIN POLICY PAGERE: Expanding the Texas AIDS Drug Assistance Program formulary to include Cabenuva (cabotegravir/rilpivirine) (July 9, 2024)
RE: Preexposure Prophylaxis (PrEP) Using Antiretroviral Therapy to Prevent Human Immunodeficiency Virus (HIV) Infection (February 9, 2023)
BACK TO LAIS MAIN POLICY PAGE